Skip to main content
. Author manuscript; available in PMC: 2006 Aug 1.
Published in final edited form as: J Comp Neurol. 2005 Aug 1;488(3):255–268. doi: 10.1002/cne.20556

Fig. 1.

Fig. 1.

Cross-reactivity of the OA-antiserum with other biogenic amines was determined with enzyme-linked immunosobent assay (ELISA). The percent inhibition (ordinate) of binding of OA-antibody is shown in relation to the concentration (abscissa) of the tested amines. The test shows no or low cross-reaction with serotonin, DOPA and dopamine. In contrast, the activity of the MAb-OA1 is inhibited by epinephrine and less so by tyramine and norepinephrine.